Revolution Medicines, Inc. (RVMD) Financials

RVMD Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 2.1 billion 262.4 million
2023-09-30 984.2 million 146.8 million
2023-06-30 1.1 billion 142.9 million
2023-03-31 1.1 billion 121.0 million

RVMD Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -122.9 million 25.4 million
2023-09-30 -103.0 million 13.7 million
2023-06-30 -68.2 million 13.0 million
2023-03-31 -64.1 million 9.7 million

RVMD Net Income

No data available :(

RVMD Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 1.9 billion - 87.9 million
2023-09-30 813.2 million - 62.8 million
2023-06-30 909.5 million - 63.3 million
2023-03-31 909.8 million - 63.6 million

RVMD Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 141.2 million
2023-09-30 109.2 million
2023-06-30 106.9 million
2023-03-31 94.8 million

RVMD Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 2.3 million 146.9 million 32.2 million 1.2 million
2023-09-30 2.5 million 107.7 million 15.5 million -
2023-06-30 1.1 million 98.0 million 14.6 million -
2023-03-31 1.8 million 68.9 million 13.2 million -

RVMD Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 742000 2.9 million
2023-09-30 - 2.1 million
2023-06-30 3.8 million 1.8 million
2023-03-31 7.0 million 2.5 million

RVMD

Price: $37.28

52 week price:
15.44
38.73

Earnings Per Share: -3.86 USD

P/E Ratio: -9.17

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Volume: 856800

Market Capitalization: 5.9 billion

Links: